

Ananda Lists on US OTCQB Market, Argent Bio Signs Data Sharing Deal With AusCann, & IMC Under New Threat of NASDAQ Delisting
Ananda Pharma Just days after welcoming the former Chief Operating Officer of GW and Jazz Pharmaceuticals to its ranks
Ananda Pharma Just days after welcoming the former Chief Operating Officer of GW and Jazz Pharmaceuticals to its ranks
Argent BioPharma Argent BioPharma has managed to overcome the wider chaos on the stock markets this week, seeing its
UK-listed medical cannabis producer Celadon Pharmaceuticals is struggling to emerge from its precarious financial position after months of turmoil.Â
Akanda Akanda Corp has become the latest listed cannabis company to announce its (partial) exit from the industry as
Aurora Cannabis Canadian cannabis giant Aurora Cannabis has seen its stock jump nearly 50% this week after publishing a
Argent BioPharma Argent Biopharma (previously MGC Pharmaceuticals) has completed a US$4.5 million capital raise to support its drug development
Argent Biopharma Argent Biopharma (previously MGC Pharmaceuticals), the first company in history to launch an IPO on the London
Akanda Corp NASDAQ-listed international medical cannabis operator Akanda Corp has seen its stock drop by double digits this week
Ananda Developments Ananda Developments’ CEO has seemingly forced the hand of one of the UK’s most popular investment service
Argent BioPharma Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.